Current concepts in the biochemical assessment of the patient with acromegaly.
about
Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease ParadigmsInterpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyFeatures at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedChorio-retinal thickness measurements in patients with acromegalyReevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of DiseaseMedical therapy of acromegalyAssociation between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly.Current pharmacotherapy for acromegaly: a review.Treatment strategies for acromegaly.Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomesNanomedicines in the treatment of acromegaly: focus on pegvisomant.Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.Leptin Receptor Gene Polymorphism may Affect Subclinical Atherosclerosis in Patients with AcromegalyHypersomatotropism in 3 Cats without Concurrent Diabetes MellitusThe PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly.Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status.Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism.Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility
P2860
Q26741707-8DE35255-19E4-49F5-BF7A-A90B2E85DDC7Q26777682-786135F7-0F73-4F73-AF54-E04B2034C260Q33835825-E7AD21D0-CB15-4BC2-A59D-382B4166AA35Q34759602-E238313C-482A-4D27-8D11-379E1E41A43DQ34815007-A8A02B2A-6F4B-4032-AB33-C4A9680F3D93Q35895856-35935B4E-7580-40D2-8492-CC6172DD4BFFQ36127589-026D958F-902A-473A-AD68-E6A97E77BCC2Q36301564-99822E14-4B1F-4BFC-ACC1-D2EAFC30071DQ36302865-B3ECFE35-FBE6-4D43-98D9-72F8994E96DBQ36845980-38DC6797-0E7F-403F-B99C-5059C11E24D7Q36890994-9BE980F1-B50B-4AF2-8F40-1EBB7949A70EQ36920317-31A1ADA1-4BD1-4256-BB31-3394552775BCQ38185306-4D122C43-4BB3-414E-A0CD-D8E983CDEF6EQ41845689-DC4424A5-0F21-4FA3-A642-ADAA58B1D5B3Q42376506-8F908CBE-6B51-41D9-A6B0-0883CA3FA5D9Q42516933-1F7824BD-A5E3-46C7-A559-5E76CA97264FQ45065721-DCFCC9BF-1699-4371-B09B-4894B2AAAD0FQ46419672-DB577E93-4BD1-4CCF-9877-863BF1363324Q46951269-F70C25D5-C8DD-4120-AC4A-353976873E8BQ50944176-BADA011D-C01E-4CFF-9B84-8D05584356D7Q51370923-214D5C26-B48F-4491-89C5-6E80F0695ECDQ51493161-0E676B91-C6DC-4A9B-AE3B-D02E0CABFE62Q53056202-A6B9ABDE-E211-4BC7-AC29-4F9A892B8EDFQ56962774-D9BD5734-EF68-42CF-9FBB-24F90ED984BC
P2860
Current concepts in the biochemical assessment of the patient with acromegaly.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Current concepts in the biochemical assessment of the patient with acromegaly.
@ast
Current concepts in the biochemical assessment of the patient with acromegaly.
@en
type
label
Current concepts in the biochemical assessment of the patient with acromegaly.
@ast
Current concepts in the biochemical assessment of the patient with acromegaly.
@en
prefLabel
Current concepts in the biochemical assessment of the patient with acromegaly.
@ast
Current concepts in the biochemical assessment of the patient with acromegaly.
@en
P1476
Current concepts in the biochemical assessment of the patient with acromegaly.
@en
P2093
Pamela U Freda
P304
P356
10.1016/S1096-6374(03)00029-7
P577
2003-08-01T00:00:00Z